HEATHER PICKETT: Open Payments
NPI 1194490185 · NOBLESVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,415 in 82 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $836 · 2025 $1,415
Food & beverage: $1,415
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $242 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $163 |
| Inari Medical, Inc. | 2 | $142 |
| Lilly USA, LLC | 6 | $126 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $121 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $79 |
| Novo Nordisk Inc | 4 | $74 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| Exact Sciences Corporation | 4 | $68 |
| Axsome Therapeutics, Inc. | 3 | $68 |
Products named: CAPLYTA, VRAYLAR, FLOWTRIEVER CATHETER, S, Kerendia, JARDIANCE, MOUNJARO, Ozempic, Auvelity.
Industry payments across IN — which companies pay providers there.
